OSSINING, N.Y. —A study out this week looked at the effects of chemotherapy on babies whose mothers were treated for cancer during pregnancy. These cases are rare — only about one in 1,000 expectant moms are diagnosed with cancer. But as women are having babies later, and cancers are being diagnosed earlier, the numbers are expected to rise.
In April, 39-year-old Gina Neri received a happy surprise. She was pregnant with her third child. But she had symptoms that led her doctor to perform to a colonoscopy.
“He said Gina, you’re looking at cancer,” said Neri of her doctor’s visit. “He knew right away. It was big.”
She was facing surgery and chemotherapy, and the prognosis for her baby was grim.
“They wanted me to know that most likely the baby wasn’t going to survive. Several doctors told us to terminate the pregnancy,” Neri said.
The fear is that treatments like chemotherapy will harm the rapidly developing fetus.
“During the first trimester, that’s when the majority of the organs of the baby are developing,” said Dr. Elyce Cardonick, who studies pregnant women with cancer. “So if at all possible, we would like to avoid chemotherapy in the first trimester.
In the new study, researchers in Europe followed 129 children whose mothers were treated for cancer primarily during their second or third trimesters. Although 79 of the children were born before full term, they had normal physical and cognitive development up to age three.
Research suggests the placenta can act as a protective filter, depending on the type of chemo.